| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/11/2002 | WO2002024933A3 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2000052187A9 Enhanced system for construction of adenovirus vectors |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090716 EHV-1 vectors |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090714 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 07/11/2002 | US20020090356 Use of bacteriophages for control of escherichia coli 0 157 |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220938A1 Materials and methods for simplified aav production |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/10/2002 | CN1358101A Method of controlling the qualities of attenuated pox vaccine |
| 07/10/2002 | CN1357622A Human interleukin-12 recombinant insect virus strain and its prepn |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6416992 Using rotation bottles; transfection; culture product |
| 07/09/2002 | US6416945 Disassembling virus-like particles of l1 proteins or mixture of l1 and l2 proteins by contacting for prolonged time period with concentrated reducing agent solution, adding moiety to be encapsulated, reassembling by removing reducing agent |
| 07/04/2002 | WO2002052015A2 Self-replicating rna molecule from hepatitis c virus |
| 07/04/2002 | WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2001085974A3 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2000073316A3 Virus immunologic determinants |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086035 Vaccines for therapy of immunomodulatory or immunoregulatory diseases |
| 07/04/2002 | US20020086033 Pestivirus mutants and vaccines containing the same |
| 07/04/2002 | US20020085999 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 07/04/2002 | DE10065504A1 Adenoviral nucleic acid useful for preventing or treating malignant or benign tumors, by inducing cell lysis, comprises a sequence for the YB-1 protein |
| 07/03/2002 | EP1219705A1 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 07/03/2002 | EP1218528A1 Producer cell for the production of retroviral vectors |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 07/03/2002 | EP1218035A2 Rapid peg-modification of viral vectors |
| 07/03/2002 | EP1218019A2 Oncolytic virus |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1087032C Process for prodn. of recombination adenovirus |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413714 Process for the sterilization of biological compositions and the product produced thereby |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6412336 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 06/27/2002 | WO2002050304A2 Oncolytic virus |
| 06/27/2002 | WO2002024147A3 Avian pneumovirus vaccine |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002020721A3 Vectors derived from south african arbovirus no. 86 |
| 06/27/2002 | WO2001074849A3 Binding peptides for carcinoembryonic antigen (cea) |
| 06/27/2002 | WO2001072994A3 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2000071726A9 Methods to inhibit infectious agent transmission during xenotransplantation |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | US20020081721 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors |
| 06/27/2002 | US20020081710 Purification of preferential viral particles; obtain solution containing viral particles, mix with polyelectrolyte, centrifuge, recover pellet, separate viral particles from pellet |
| 06/27/2002 | US20020081706 Negative strand rna viral vector having autonomous replication capability |
| 06/27/2002 | US20020081316 Vector and recombinant vaccines made therefrom useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081280 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/26/2002 | EP1216054A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 06/26/2002 | EP1216053A2 Influenza vaccine |
| 06/26/2002 | EP0773785B1 Treatment of cancer using hsv mutant |
| 06/26/2002 | CN1355851A Paramyxorividae virus vector defective in envelope gene |
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410313 Gene delivery system and methods of use |
| 06/25/2002 | US6410300 Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410298 Reducing frequency homologous recombination; obtain cells, transform with defective nucleotide sequences, monitor homoogous recombination in cells |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410257 Methods to assay gene function with viral vectors |
| 06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
| 06/25/2002 | US6410033 Virus comprising foreign dna sequence inserted into genome which is capable of being expressed in infected host cell |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410031 Attentuated porcine reproductive and respiratory syndrome virus strain and method of use |
| 06/25/2002 | US6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2123612C Hybrid protein between cs from plasmodium and h bsag |
| 06/25/2002 | CA2006412C Eimeria tenella vaccine |
| 06/21/2002 | CA2327189A1 Novel dna-based vaccine against the encephalitis alphaviruses |
| 06/20/2002 | WO2002048375A2 Purified active hcv ns2/3 protease |
| 06/20/2002 | WO2002018426A3 Rabbit hemorrhagic disease vaccine and antigens |
| 06/20/2002 | WO2001095933A3 Immunization through oral administration of a vaccine with an edible product |
| 06/20/2002 | WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | US20020076808 Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products |
| 06/20/2002 | US20020076801 AAV DNA comprising helper virus sequences |
| 06/20/2002 | US20020076773 Nucleic acid amplification controls |
| 06/20/2002 | US20020076692 Ribosome display |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/19/2002 | EP1214410A1 Chimaeric plant viruses with mucin peptides |
| 06/19/2002 | EP1214352A2 Enhanced phage display libraries of human vh fragments and methods for producing same |
| 06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP0870050B1 Toxic-protein expressing viruses and producer cell lines |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0611397B1 Feline leukemia virus vaccines |
| 06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
| 06/19/2002 | CN1354788A Cyclic peptides |